Mori Arkin

$1.47B

as of 10/04/24

About Mori Arkin

Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company.

The Arkins eventually moved into generic drug manufacturing, founding Agis Industries.

In 2004, they sold Agis to U.S. pharmaceutical company Perrigo for $818 million in cash and stock.

Still bullish on healthcare, he oversaw a January 2018 public offering on Nasdaq of Sol-Gel Technologies, a dermatology company. He owns over 62%.

Personal stats

Citizenship

Israel

Source of wealth

Pharmaceuticals

Residence

Herzliya Pituach, Israel

Marital status

Married

Birth date

09/24/52 (age 72)

Number of children

Education

Bachelor of Arts/Science, Tel Aviv University

Self-made

self-made

Mori Arkin’s fortune is worth

24K

troy ounces of gold

23K

median U.S. household

15K

median U.S. income

0.029%

U.S. credit card volume

0.006%

GDP of the United States

0.004%

United States debt

Net worth history

Annual ranking

Did you know?

His two sons are involved in the family business; his daughter is serving in the Israel Defense Forses.

Net worth over time

Real-time ranking

Financial assets

NYSE | ARGO-US

Argo Group International Holdings

TEL AVIV | CLIS-IL

Clal Insurance Enterprises Holdings

NYSE | DOCN-US

DigitalOcean

NASDAQ | KROS-US

Keros Therapeutics

TEL AVIV | NVLG-IL

Novolog

US OTC | ODYS-US

Odysight.ai Inc.

US OTC | ONCR-US

Oncorus

NASDAQ | SLGL-US

Sol-Gel Technologies

NYSE | SG-US

Sweetgreen

NASDAQ | URGN-US

UroGen Pharma